Lora L. Pike
Geen lopende functies
Profiel
Lora L.
Pike worked as an Associate Director of Investor Relations at Vertex Pharmaceuticals, Inc. in 2009.
She then worked as a Senior Director of Investor Relations at Keryx Biopharmaceuticals, Inc., Momenta Pharmaceuticals, Inc., and Agios Pharmaceuticals, Inc.
Eerdere bekende functies van Lora L. Pike
| Bedrijven | Functie | Einde |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Investor Relations Contact | 12-12-2018 |
| MOMENTA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
